MedTrace Logo

Feasibility of a Digital Therapeutic for Adults With Binge Eating and Obesity

NCT06454123 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-06-12

No results posted yet for this study

Summary

The primary objective of this study is to test the feasibility of a digital therapeutic to address comorbid binge eating and obesity in adults.

Conditions

Interventions

DEVICE

OTX-401

Evidence-based treatments for obesity and binge eating

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Oui Therapeutics, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2025-03-31
Completion
2025-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06454123 on ClinicalTrials.gov